Published in J Virol on January 01, 1993
Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol (1994) 3.59
pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J Virol (1994) 2.87
Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol (1994) 2.36
Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J Virol (1997) 2.24
A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J Virol (1998) 1.89
Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J Virol (2000) 1.72
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol (1997) 1.70
Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J Virol (1994) 1.69
A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease. J Virol (1994) 1.65
Sequences determining the pH dependence of viral entry are distinct from the host range-determining region of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol (1993) 1.58
Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide. J Virol (1996) 1.35
Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein. J Virol (1999) 1.35
Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J Virol (1998) 1.33
Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity. J Virol (1997) 1.31
A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system. J Virol (1994) 1.25
Functional domains in the retroviral transmembrane protein. J Virol (1998) 1.21
Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion. J Virol (2001) 1.19
Functional interactions between monomers of the retroviral envelope protein complex. J Virol (1997) 1.17
Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E. J Virol (1998) 1.15
Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J Virol (1993) 1.14
Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes. J Virol (1995) 1.11
Oligomerization of fusogenic peptides promotes membrane fusion by enhancing membrane destabilization. Biophys J (2004) 1.09
Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. EMBO J (1997) 1.07
Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J Virol (1996) 1.07
Fv-4: identification of the defect in Env and the mechanism of resistance to ecotropic murine leukemia virus. J Virol (2001) 1.05
Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction. J Virol (1999) 1.04
Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J Virol (1998) 1.04
Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein. J Virol (1999) 1.04
The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins. J Virol (1998) 1.04
TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J Virol (1996) 1.02
Receptor-mediated Moloney murine leukemia virus entry can occur independently of the clathrin-coated-pit-mediated endocytic pathway. J Virol (1999) 1.01
Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis. J Virol (2003) 1.01
Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env. J Virol (2008) 0.99
Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide. J Virol (2001) 0.98
Functional characterization of the N termini of murine leukemia virus envelope proteins. J Virol (2001) 0.91
Generation of novel syncytium-inducing and host range variants of ecotropic moloney murine leukemia virus in Mus spicilegus. J Virol (2003) 0.89
Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein. J Virol (2000) 0.88
Functional analysis of the putative fusion domain of the baculovirus envelope fusion protein F. J Virol (2004) 0.88
Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus. J Virol (1996) 0.87
Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion. J Virol (2006) 0.87
Retracted Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro. J Virol (1996) 0.84
Infection of XC cells by MLVs and Ebola virus is endosome-dependent but acidification-independent. PLoS One (2011) 0.83
Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes. J Virol (1997) 0.83
G100R mutation within 4070A murine leukemia virus Env increases virus receptor binding, kinetics of entry, and viral transduction efficiency. J Virol (2003) 0.81
Retrovirus entry by endocytosis and cathepsin proteases. Adv Virol (2012) 0.79
Library screening and receptor-directed targeting of gammaretroviral vectors. Future Microbiol (2013) 0.79
JC virus T-antigen regulates glucose metabolic pathways in brain tumor cells. PLoS One (2012) 0.78
N-Linked glycosylation is required for XC cell-specific syncytium formation by the R peptide-containing envelope protein of ecotropic murine leukemia viruses. J Virol (2003) 0.77
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
Plaque assay techniques for murine leukemia viruses. Virology (1970) 29.21
Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science (1987) 13.52
Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res Hum Retroviruses (1987) 7.85
Virus entry into animal cells. Adv Virus Res (1989) 7.78
Membrane fusion proteins of enveloped animal viruses. Q Rev Biophys (1983) 6.31
Viral and cellular membrane fusion proteins. Annu Rev Physiol (1990) 6.13
Expression of human class II major histocompatibility complex antigens using retrovirus vectors. Proc Natl Acad Sci U S A (1987) 4.84
Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells. Proc Natl Acad Sci U S A (1980) 4.71
Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci U S A (1990) 4.64
Nucleotide sequence of AKV murine leukemia virus. J Virol (1984) 4.58
Protein-mediated membrane fusion. Annu Rev Biophys Biophys Chem (1989) 3.99
Identification of the fusion peptide of primate immunodeficiency viruses. Science (1989) 3.83
The pH independence of mammalian retrovirus infection. J Gen Virol (1990) 3.68
Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol (1986) 3.56
Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus: synthesis, identification, and processing. Virology (1976) 3.26
Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides. Nature (1984) 2.10
The role of envelope glycoprotein processing in murine leukemia virus infection. J Virol (1987) 2.06
Fusion of Rous sarcoma virus with host cells does not require exposure to low pH. J Virol (1990) 1.97
Entry of murine retrovirus into mouse fibroblasts. Virology (1983) 1.96
Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J Virol (1989) 1.83
A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations. Virology (1989) 1.78
Ecotropic murine leukemia virus-induced fusion of murine cells. J Virol (1986) 1.56
Mouse mammary tumor virus can mediate cell fusion at reduced pH. Virology (1984) 1.56
Inhibitors of oligosaccharide processing. Biochim Biophys Acta (1985) 1.51
Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology (1985) 1.49
High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice. Proc Natl Acad Sci U S A (1981) 1.38
Infectious entry of murine retroviruses into mouse cells: evidence of a postadsorption step inhibited by acidic pH. J Virol (1985) 1.37
Fusion activity of virions of murine leukemia virus. Virology (1979) 1.10
Retrovirus-induced cell fusion is enhanced by protease treatment. J Gen Virol (1989) 1.10
Replication-defective ecotropic murine leukemia viruses: Detection and quantitation of infectivity using helper-dependent XC plaque formation. J Virol (1978) 1.03
Induction of syncytia by Moloney murine leukemia virus in myoblasts defective in differentiation. J Virol (1977) 0.99
Mechanism of murine leukemia virus-induced fusion in rat myoblasts defective in differentiation. J Virol (1977) 0.99
A chimera of EBNA1 and the estrogen receptor activates transcription but not replication. J Virol (1992) 0.98
Glycosylation of the envelope glycoprotein from a polytropic murine retrovirus in two different host cells. Eur J Biochem (1990) 0.89
Cleavage fragments of the retrovirus surface protein gp70 during virus entry. J Gen Virol (1987) 0.89
Formation of syncytia in human lymphoblastoid cells infected with type C viruses. Virology (1973) 0.88
Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci U S A (1975) 6.59
Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci U S A (1990) 4.64
Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J Virol (1991) 4.37
A nonselective analysis of SV40 transformation of mouse 3T3 cells. Virology (1974) 4.37
Plasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cells by simian virus 40. Proc Natl Acad Sci U S A (1974) 2.59
Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. J Virol (1989) 2.58
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry (2000) 2.34
The role of envelope glycoprotein processing in murine leukemia virus infection. J Virol (1987) 2.06
Abelson virus-induced lymphomagenesis in mice. J Exp Med (1978) 1.81
Cardiopulmonary resuscitation in the delivery room. Associated clinical events. Arch Pediatr Adolesc Med (1995) 1.71
Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas. J Virol (1984) 1.63
One retroviral RNA is sufficient for synthesis of viral DNA. J Virol (1994) 1.60
Molecular and biological characterization of the endogenous ecotropic provirus of BALB/c mice. J Virol (1985) 1.45
The stable classes of transformed cells induced by SV40 infection of established 3T3 cells and primary rat embryonic cells. Cold Spring Harb Symp Quant Biol (1975) 1.41
Isolation and characterization of revertant cell lines. 3. Isolation of density-revertants of SV40-transformed 3T3 cells using colchicine. J Cell Physiol (1973) 1.40
Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. Pediatrics (1996) 1.35
Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice. Proc Natl Acad Sci U S A (1978) 1.32
Endogenous mouse leukemia viruses. Annu Rev Genet (1983) 1.30
Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells. J Virol (1982) 1.26
Alteration of location of dimer linkage sequence in retroviral RNA: little effect on replication or homologous recombination. J Virol (1993) 1.21
Genetic interactions in induction of endogenous murine leukemia virus from low leukemic mice. Cell (1982) 1.21
Structure and expression of endogenous ecotropic murine leukemia viruses in RF/J mice. J Exp Med (1982) 1.19
Identification of conserved residues in the human immunodeficiency virus type 1 principal neutralizing determinant that are involved in fusion. AIDS Res Hum Retroviruses (1991) 1.16
Is there a role for continuation phase cognitive therapy for depressed outpatients? J Consult Clin Psychol (1998) 1.16
Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics (1994) 1.16
Abelson antigen is expressed on hematopoietic spleen colony-forming cells from mice carrying the Av-2S virus sensitivity gene. Proc Natl Acad Sci U S A (1979) 1.15
Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis. J Virol (1987) 1.14
Genetic interactions in the spontaneous production of endogenous murine leukemia virus in low leukemic mouse strains. J Exp Med (1982) 1.13
A locus that enhances the induction of endogenous ecotropic murine leukemia viruses is distinct from genome-length ecotropic proviruses. J Virol (1982) 1.10
Allelism and linkage studies of murine leukemia virus activation genes in low leukemic strains of mice. J Exp Med (1982) 1.10
Multiple steps are required for the induction of tumors by Abelson murine leukemia virus. J Virol (1989) 1.09
Mechanism of interaction between endogenous ecotropic murine leukemia viruses in (BALB/c X C57BL/6) hybrid cells. Virology (1988) 1.06
Molecular cloning and characterization of mouse mammary tumor proviruses from a T-cell lymphoma. J Virol (1986) 1.05
Factors affecting the frequency of transformation of rat embryo cells by simian virus 40. Virology (1979) 1.04
Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch Neurol (1997) 1.03
Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus. J Exp Med (1979) 1.03
Germ line integration of a murine leukemia provirus into a retroviruslike sequence. J Virol (1987) 1.02
Nucleotide conservation of endogenous ecotropic murine leukemia proviruses in inbred mice: implications for viral origin and dispersal. Virology (1987) 1.02
Action of Escherichia coli P1 restriction endonuclease on simian virus 40 DNA. J Mol Biol (1974) 1.00
Can asphyxiated infants at risk for neonatal seizures be rapidly identified by current high-risk markers? Pediatrics (1996) 0.99
Relationship between periventricular intraparenchymal echodensities and germinal matrix-intraventricular hemorrhage in the very low birth weight neonate. Pediatrics (1993) 0.97
Relative locations of rearrangements in the DNA of defective simian virus 40 (SV40). Virology (1974) 0.97
Regulation of expression of T cell gamma chain, L3T4 and Ly-2 messages in Abelson/Moloney virus-transformed T cell lines. Eur J Immunol (1988) 0.96
Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms. Oncogene Res (1989) 0.95
The pathogenesis of Abelson virus lymphomas of the mouse. Biochim Biophys Acta (1982) 0.95
Different genes control the susceptibility of mice to Moloney or Abelson murine leukemia viruses. J Virol (1985) 0.95
Phenotypic variation in clonal Abelson virus lymphoma cells. J Immunol (1985) 0.94
Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus. Proc Natl Acad Sci U S A (1987) 0.93
Induction of plasmacytomas secreting antigen-specific monoclonal antibodies with a retrovirus expressing v-abl and c-myc. Proc Natl Acad Sci U S A (1991) 0.93
A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas. Oncogene (1992) 0.92
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology (1999) 0.91
Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation (1992) 0.89
Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer. Gynecol Oncol (1991) 0.88
Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989. Early Hum Dev (1991) 0.87
TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein. J Virol (1993) 0.87
Effect of maternal hypertension on neonatal neutropenia and risk of nosocomial infection. Pediatrics (1992) 0.87
Reducing relapse in depressed outpatients with atypical features: a pilot study. Psychother Psychosom (2000) 0.86
Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors. Oncogene (1988) 0.86
Activation of nonexpressed endogenous ecotropic murine leukemia virus by transfection of genomic DNA into embryo cells. J Virol (1983) 0.86
Production of anti-self H-2 antibodies by hybrid mice immune to a viral tumour. Nature (1981) 0.86
Relationship of uric acid concentrations and severe intraventricular hemorrhage/leukomalacia in the premature infant. J Pediatr (1998) 0.84
Structures and activities of activated abl oncogenes. Curr Top Microbiol Immunol (1989) 0.83
Intraobserver and interobserver reliability in assessment of neonatal cranial ultrasounds. Early Hum Dev (1991) 0.83
Interference established in mice by infection with Friend murine leukemia virus. J Virol (1992) 0.83
Cell-surface antigens of Abelson and Friend murine leukemia viruses and of hematopoietic differentiation. Cold Spring Harb Symp Quant Biol (1980) 0.82
WHO Working Group on Characterization of HIV-Related Retroviruses: criteria for characterization and proposal for a nomenclature system. AIDS (1987) 0.82
Copackaging of different-sized retroviral genomic RNAs: little effect on retroviral replication or recombination. J Virol (1994) 0.82
A retrovirus expressing v-abl and c-myc induces plasmacytomas in 100% of adult pristane-primed BALB/c mice. Curr Top Microbiol Immunol (1990) 0.81
Adenosquamous carcinoma of the cervix: prognosis in stage IB. Obstet Gynecol (1990) 0.80
Xenon-133 SPECT-determined regional cerebral blood flow in Alzheimer's disease: what is typical? J Neuropsychiatry Clin Neurosci (1993) 0.79
Severe fetal acidemia: neonatal neurologic features and short-term outcome. Pediatr Neurol (1993) 0.79
The activity of an ABL-MYC retrovirus in fibroblast cell lines and in lymphocytes. Curr Top Microbiol Immunol (1990) 0.79
P80: a tumor-related protein found in many lymphomas of mice. J Exp Med (1982) 0.79
Randomized, double-blinded, placebo-controlled trial of amoxicillin/clavulanic acid to prevent preterm delivery in twin gestation. Infect Dis Obstet Gynecol (1995) 0.78
Cognitive deficits in asymptomatic first-degree relatives of Alzheimer's disease patients. J Clin Exp Neuropsychol (1994) 0.78
Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells. J Virol (1990) 0.77
Early use of the Gore-Tex Stretch Graft. Blood Purif (1996) 0.77
Verapamil improves the outcome after cadaver renal transplantation. J Am Soc Nephrol (1991) 0.77
Thymic targets for Abelson murine leukemia virus are early gamma/delta T lymphocytes. Proc Natl Acad Sci U S A (1991) 0.77
Susceptibility to Abelson or Moloney murine leukemia viruses. Curr Top Microbiol Immunol (1985) 0.76
Determinants of Abelson murine leukemia virus pathogenesis. Curr Top Microbiol Immunol (1986) 0.76
Behavior in traffic conflict situations. Accid Anal Prev (1985) 0.75
Cyclosporine therapy in pancreas transplantation. Transplant Proc (1996) 0.75
Knowing proper interview questions will help you find the best employees. Dent Off (1990) 0.75
Watch legal pitfalls when giving out references for former employees. Dent Off (1990) 0.75
Pentafraction-Du Pont versus albumin for resuscitation of a lethal intestinal ischemic shock in rats. Circ Shock (1991) 0.75
The pathogenesis of tumors induced by helper virus-free Abelson murine leukemia virus. Curr Top Microbiol Immunol (1988) 0.75
Monoclonal antibody to Abelson lymphoma cells. Curr Top Microbiol Immunol (1984) 0.75
When it comes to pregnant employees all parties should know their rights. Dent Off (1991) 0.75
Perioperative albumin and verapamil improve early outcome after cadaver renal transplantation. Transplant Proc (1994) 0.75
Discipline system improves performance, avoids dismissals. Dent Off (1991) 0.75
Verapamil (VP) improves the outcome after renal transplantation (CRT). Transpl Int (1992) 0.75
Prognosis of ovarian cancer developing in the residual ovary. Gynecol Oncol (1991) 0.75